Mark G. Foletta

Mark G. Foletta

Lead Independent DirectoratDexcom· In proxies 2023–2025

Mark G. Foletta sits on 8 public boards.

Boards1

  • DexcomLead independent director · 10 yr on the boardNot independentAudit (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. DexcomPublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrStock in role -28%
  2. Amn Healthcare ServicesPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  3. Enanta PharmaceuticalsPublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrNo stock prices for these years
  4. Enanta PharmaceuticalsPublic company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  5. AMN Healthcare Services, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Audit Committee of AMN Healthcare Services, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Audit Committee of Enanta Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Regulus Therapeutics Inc.Public company · 5 yr
    • Director2013 – 2018 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?